After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If finalized as proposed, FDA would ...

Those familiar with AI know it performs best when working with well-curated, human-generated data or documents, and rarely excels at creating content entirely on its own. While AI is making remarkable ...

You’ve just finished a clinic visit with your primary care provider, and you’ve been sent to the lab for a blood test. What happens next?